Interpharm Holdings Current Ratio 1971-1970 | IPAH

Interpharm Holdings current ratio from 1971 to 1970. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Interpharm Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
Sector Industry Market Cap Revenue
Medical MED-GENERIC DRG $0.000B $0.000B
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. The Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) IL $17.711B 6.48
Dr Reddy's Laboratories (RDY) IN $11.545B 22.02
BridgeBio Pharma (BBIO) US $7.291B 0.00
Bausch Health Cos (BHC) CA $1.958B 1.41
Supernus Pharmaceuticals (SUPN) US $1.817B 16.90
Amphastar Pharmaceuticals (AMPH) US $1.134B 6.86
Taysha Gene Therapies (TSHA) US $0.494B 0.00
Personalis (PSNL) US $0.341B 0.00
Assembly Biosciences (ASMB) US $0.087B 0.00
Sol-Gel Technologies (SLGL) IL $0.022B 0.00
Evoke Pharma (EVOK) US $0.004B 0.00
Teligent (TLGT) US $0.000B 0.00